Antibiotics R&D
The Rebirth of Antibiotic R&D: New Momentum for an Old Crisis
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-25-NI-05Dec 10, 2025
EU Overhaul
Europe’s Pharma Overhaul: How the New Incentive Model Will Reshape Global Innovation Strategy
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-25-NI-06Nov 18, 2025
Antibiotics
Kineticos Launches Kinvard Bio to Advance Next-Generation Antibiotics in the Fight Against Antimicrobial Resistance
Kinvard Bio
PR-02-25-NI-27Feb 24, 2025
Molecular Machines
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-24-NI-02Jan 22, 2024
Antibiotic Resistance
Antibiotic Resistance: Advances in Understanding and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-07Oct 11, 2022
Antimicrobial
Preserving the Value of Critical Anti-Infectives
Centrient Pharmaceuticals
PAO-04-22-R221-20Apr 14, 2021
Antibiotics
Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe
Sandoz
PR-M07-20-NI-38Jul 27, 2020
Nice Insight Overview
Drug Approval Trends: Significant Acceleration in Recent Years
Nigel Walker
Nice Insight
PAP-Q2-20-NI-001Jul 1, 2020
Molecules
Molecules that Changed Medicine
David Alvaro, Ph.D.; Emilie Branch; Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-002Jul 1, 2020
Novel Antibiotics
Applying a Synthetic Approach to the Development of a New Generation of Antibiotics
James Graham
Recce Pharmaceuticals Ltd.
PAP-Q2-20-CL-019Jul 1, 2020
FDA Approval
FDA Approves New Antibiotic to Treat Community-Acquired Bacterial Pneumonia
U.S. Food & Drug Administration
PR-M08-19-NI-061Aug 21, 2019
FDA Approval
U.S. FDA Approved New Antibacterial for Urinary Tract and Abdominal Infections
Pharma's Almanac
PAO-M08-19-NI-015Aug 7, 2019
Antibiotics
UK Hopes Subscription Payment Model Will Drive Innovation in Antibiotics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-006Aug 1, 2019
Priority Review
Melinta’s Antibiotic Baxdela Gets Priority Review from FDA for CAPB
Pharma's Almanac
PAO-M07-19-NI-005Jul 1, 2019
Antibiotic Resistant
FIU Scientists Discover New Arsenic-Based Broad-Spectrum Antibiotic
Florida International University
PR-M04-19-NI-058Apr 18, 2019
Antibiotics
Infectious Diseases Experts Convene to Explore Lifesaving Antibiotic Research Methods
Nice Insight
PR-M11-18-NI-052Nov 15, 2018
Investment
Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections
Qpex Biopharma
PR-M10-18-NI-087Oct 25, 2018
Antibiotics
PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections
PolyPid
PR-M10-18-NI-070Oct 19, 2018
Antibiotics
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries
Menarini Group
PR-M10-18-NI-048Oct 15, 2018
Drug Development
New Antibiotic to be Tested against Potential Bioweapons
Emilie Branch
Pharma's Almanac
PAO-M07-18-NI-009Jul 17, 2018